AnaptysBio Inc.

NASDAQ: ANAB · Real-Time Price · USD
20.08
0.11 (0.55%)
At close: Aug 15, 2025, 1:23 PM

AnaptysBio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
91.28M 17.16M 10.29M 63.17M
Cost of Revenue
n/a 2.38M 2.33M 98.5M
Gross Profit
91.28M 14.78M 7.95M -35.32M
Operating Income
-114.95M -164.41M -115.15M -56.81M
Interest Income
19.79M 18.87M 7.55M 431K
Pretax Income
-145.23M -163.62M -128.7M -57.8M
Net Income
-145.23M -163.62M -128.72M -57.19M
Selling & General & Admin
42.39M 41.95M 36.64M 21.49M
Research & Development
163.84M 132.28M 88.8M 98.5M
Other Expenses
n/a 7.34M 12K 37K
Operating Expenses
206.23M 181.57M 125.44M 119.99M
Interest Expense
50.09M 18.08M 21.11M 1.45M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
206.23M 181.57M 125.44M 119.99M
Income Tax Expense
3K -4K 24K -603K
Shares Outstanding (Basic)
28.38M 26.92M 28.16M 27.43M
Shares Outstanding (Diluted)
28.38M 26.92M 28.16M 27.43M
EPS (Basic)
-5.12 -6.08 -4.57 -2.08
EPS (Diluted)
-5.12 -6.08 -4.57 -2.08
EBITDA
-92.74M -143.16M -105.26M -55.71M
EBIT
-95.14M -145.54M -107.59M -56.35M
Depreciation & Amortization
2.4M 2.38M 2.33M 2.09M